![]() |
|
|
Sign-up for Influenza News
|
Vaccine Manufacture :
Reassortment A flu virus contains eight gene segments. One of the gene segments codes for the surface antigen
hemagglutinin (HA), and another codes for the surface antigen neuraminidase (NA). Each year,
researchers predict which flu strains will be most prevalent and select three – two influenza A strains and
an influenza B strain – to be included in that year’s vaccine.
The goal of reassortment is to combine the desired HA and NA antigens from the target strain (flu strain
1) with genes from a harmless strain that grows well in an egg (flu strain 2).
The illustration to the right details the following steps in creating the vaccine:
Click the illustration to the right to see it in full size.
More recently an alternative technique to Reassortment has been developed, called Reverse Genetics. This can been used to modify the virus to render it non-pathogenic to eggs – enabling avian strains like H5N1 to be successfully grown in eggs. This technique is also described in the above link and in the Pandemic Production section.
Page last updated: 6/10/2008 12:25:06 PM
|